Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Neutralizing antibody responses induced by varicella-zoster virus gE and gB glycoproteins following infection, reactivation or immunization.

Haumont M, Jurdan M, Kangro H, Jacquet A, Massaer M, Deleersnyder V, Garcia L, Bosseloir A, Bruck C, Bollen A, Jacobs P.

J Med Virol. 1997 Sep;53(1):63-8.

PMID:
9298734
2.

Formation of native hepatitis C virus glycoprotein complexes.

Deleersnyder V, Pillez A, Wychowski C, Blight K, Xu J, Hahn YS, Rice CM, Dubuisson J.

J Virol. 1997 Jan;71(1):697-704.

3.

Purification, characterization and immunogenicity of recombinant varicella-zoster virus glycoprotein gE secreted by Chinese hamster ovary cells.

Haumont M, Jacquet A, Massaer M, Deleersnyder V, Mazzu P, Bollen A, Jacobs P.

Virus Res. 1996 Feb;40(2):199-204.

PMID:
8725116
4.

Purification and characterization of recombinant varicella-zoster virus glycoprotein gpII, secreted by Chinese hamster ovary cells.

Jacquet A, Massaer M, Haumont M, Houard S, Deleersnyder V, Place M, Bollen A, Jacobs P.

Protein Expr Purif. 1995 Feb;6(1):91-8.

PMID:
7756843
5.

Site-directed mutagenesis of human myeloperoxidase: further identification of residues involved in catalytic activity and heme interaction.

Jacquet A, Garcia-Quintana L, Deleersnyder V, Fenna R, Bollen A, Moguilevsky N.

Biochem Biophys Res Commun. 1994 Jul 15;202(1):73-81.

PMID:
8037771
6.

Site-directed mutants of human myeloperoxidase. A topological approach to the heme-binding site.

Jacquet A, Deleersnyder V, Garcia-Quintana L, Bollen A, Moguilevsky N.

FEBS Lett. 1992 May 11;302(2):189-91.

Supplemental Content

Loading ...
Support Center